螺內酯 / 安達通 Spironolactone × 女性雄性禿 (FPHL)
結論：證據支持但有警示
Spironolactone 用於 FPHL 明確為 OFF-LABEL（FDA、EMA、TFDA 均未核准任何掉髮適應症；FDA 核准適應症限於 NYHA III-IV 心衰竭、高血壓附加治療、肝硬化腹水、原發性醛固酮過多症）。
A 🔵 A 中度證據 附警語發布 ⚠️ medium — moderate promotional content
Spironolactone 用於 FPHL 明確為 OFF-LABEL（FDA、EMA、TFDA 均未核准任何掉髮適應症；FDA 核准適應症限於 NYHA III-IV 心衰竭、高血壓附加治療、肝硬化腹水、原發性醛固酮過多症）。
雖然 off-label 用途無 pivotal RCT，但有多份系統性回顧與統合分析支持其療效：2023 年 Cureus meta-analysis (PMID 37719557) 顯示整體改善率 56.6%、合併 minoxidil 達 65.8%；Cleveland Clinic 開放標籤試驗顯示 200 mg/day 在 12 個月時 44% 改善；AAD 認可約 40% 有效。
Mayo Clinic、Harvard Health、AAD、Cleveland Clinic 一致將其列為女性 FPHL（特別是未停經、PCOS、minoxidil 反應不佳者）的標準 off-label 第二線選項，使用逾 20 年安全紀錄良好。
此外，整體證據為小型 RCT 與觀察性研究（非 pivotal trial），且仍有重要安全限制（孕婦禁用、需避孕、高血鉀監測），故無法給 A，給 B 為合理。
⚖️
評分透明度
所有分數由 7 層證據引擎計算，過程公開可查原始分數 0.74
D
C
B
A
S
← 反證據 / 無效有效 / 強證據 →
最終評級
A · 附警語發布
信心度
90%
證據方向一致性高
證據層級
E2
多篇高品質統合分析（≥2 篇一致）
▸查看完整決策路徑（audit trail）
- compute_raw_score — 加權公式: L2×0.30 + L3×0.25 + L5×0.25 + L11×0.10 + L1×0.10 = 0.745
- tier_from_score — 依分數區間映射至 tier letter
- apply_hec_rules — 無高階證據可裁決
- tier_strict_requirement_check — Tier 條件達標，未降階
- detect_disputes — 偵測到 0 個 hard + 0 個 soft dispute
- decide_status — 依 tier + dispute 結果決定 status
The Efficacy and Safety of Oral Spironolactone in the Treatment of Female Pattern Hair Loss: A Systematic Review and Meta-Analysis
— 詳細結論請見 PubMed 原文
前往 PubMed
The Efficacy and Safety of Oral and Topical Spironolactone in Androgenetic Alopecia Treatment: A Systematic Review
— 詳細結論請見 PubMed 原文
前往 PubMed
Efficacy and safety profile of oral spironolactone use for androgenic alopecia: A systematic review
— 詳細結論請見 PubMed 原文
前往 PubMed
Safety of Antiandrogens for the Treatment of Female Androgenetic Alopecia with Respect to Gynecologic Malignancies
— 詳細結論請見 PubMed 原文
前往 PubMed
L4a US FDA
支持
Spironolactone has been shown to be a tumorigen in chronic toxicity studies in rats. Spironolactone should be used only in those conditions described under INDICATIONS AND USAGE. Unnecessary use of this drug should be avoided. ALDACTONE is indicated for: Treatment of NYHA Class III-IV heart failure and reduced ejection fraction to increase survival, manage edema, and to reduce the need for hosp… 來源↗
L4b EU EFSA
支持
Qaialdo received marketing authorization on 26 May 2023. It is authorized to manage refractory oedema associated with congestive heart failure; hepatic cirrhosis with ascites and oedema, malignant ascites, nephrotic syndrome, and for diagnosis and treatment of primary aldosteronism and essential hypertension. The medicine can only be obtained with a prescription, and children should only be tre… 來源↗
L4c UK NHS
支持
It's used to treat: swelling, in the ankles, feet and other parts of the body, caused by fluid build-up (oedema), heart failure, high blood pressure (hypertension) if other medicines have not worked. It's only available with a prescription. Spironolactone is not usually recommended during pregnancy. This is because it can potentially affect a baby's development. [Serious side effects include] h… 來源↗
L4d TW TFDA / 衛福部
支持
安達通錠25 毫克 Aldactone Tablets 25 mg 衛署藥輸字第022610號 本藥須由醫師處方使用。適應症：利尿、高血壓、原發性醛類脂醇過多症。孕婦用藥分級：D 級。高血鉀症徵象(有高達26%病人發生，即使與Thiazide 利尿劑合用亦如此)。 來源↗
L4e WHO
支持
Spironolactone is an aldosterone receptor antagonist used to treat edema, hypertension, heart failure, and aldosteronism. More specifically, its antimineralocorticoid activity is responsible for its therapeutic efficacy in the treatment of edema, high blood pressure, heart failure, hyperaldosteronism, and ascites due to cirrhosis. Additionally, spironolactone reduces the rate of testosterone pr… 來源↗
L5a NIH Office of Dietary Supplements
支持
Spironolactone tablets are indicated for: (1) the treatment of NYHA Class III-IV heart failure and reduced ejection fraction to increase survival, manage edema, and to reduce the need for hospitalization for heart failure, and (2) use as an add-on therapy for the treatment of hypertension, to lower blood pressure. Additionally, spironolactone is indicated for the management of edema in adult pa… 來源↗
L5b Mayo Clinic
支持
Spironolactone (Aldactone), which is taken in a pill, seems to work best in women who haven't yet reached menopause. It is not approved by the U.S. Food and Drug Administration for hair loss, but it's helpful for hair loss. Spironolactone shouldn't be taken if you're pregnant or intending to become pregnant. Sometimes, it can cause headaches, breast tenderness or irregular menstrual periods, bu… 來源↗
L5c Cleveland Clinic
支持
Of the antiandrogen drugs used off-label, it is the one most commonly used. It has been used to treat female pattern hair loss for over two decades and has a good safety profile. An open-label trial showed that spironolactone 200 mg daily improved hair regrowth in 44% of patients at 12 months, which was comparable to cyproterone acetate. 來源↗
L5d Harvard Health
支持
Some women who don't respond to minoxidil may benefit from the addition of the diuretic drug spironolactone (Aldactone) for treatment of androgenic alopecia because this drug has anti-androgen properties. This medication is especially helpful for women with polycystic ovary syndrome (PCOS) because they tend to make excess androgens. Doctors will usually prescribe spironolactone together with an… 來源↗
L5e Specialty Society (condition-mapped)
支持
Oral spironolactone is a prescription medication that women can take to prevent further hair loss and increase hair thickness. Studies show that it is effective in about 40% of women who have female pattern hair loss. 來源↗
PTT · Dcard · Mobile01 彙整自公開論壇討論，非統計抽樣，僅反映社群風向。
廣告 / 業配密度 中度
低中高
📍立場總覽
PTT hair_loss 板與台灣中文衛教部落格普遍將螺內酯（安達通 Aldactone）視為女性雄性禿（FPHL）的「仿單外（off-label）」治療選項，並非 FDA 核准的雄性禿用藥（原核准為高血壓、水腫、心衰竭），但因抗雄性素機轉常被皮膚科醫師處方給高雄性素或 PCOS 相關掉髮的女性，並建議搭配 Minoxidil 使用、定期監測血鉀。
💬社群實感
意見分歧
破解迷思 社群最常見的 5 個誤解
✓
事實誤以為安達通是 FDA 核准的女性雄性禿用藥，實際上為仿單外使用（原核准適應症為高血壓、水腫、心衰竭、腹水）
✓
事實誤以為螺內酯與柔沛（Finasteride）作用相同，實際上前者是抗雄性素受體拮抗，後者是 5α-還原酶抑制劑
✓
事實誤以為初期掉髮加劇代表藥物無效，實際上常為換髮期（telogen shedding）的正常反應
✓
事實誤以為可自行向藥局購買，實際上在台灣為處方藥需醫師開立
✓
事實誤以為男性也能服用，實際上男性服用會造成女乳症等女性化副作用，不適用於男性雄性禿
🩹 社群通報的副作用
- 頻尿、口渴（利尿劑作用，劑量越高越明顯）
- 月經週期紊亂、經期不規則
- 乳房脹痛、乳房腫大
- 頭暈、姿勢性低血壓
- 空腹服用胃痛、噁心；高血鉀風險需定期抽血監測
🏷️ 社群熱議品牌
依論壇被提及頻率，非銷售或品質排序。
- 安達通 Aldactone（Pfizer 輝瑞）
- 愛達信錠 Aldactone 25mg
- 適立復錠 Spirono
- 皮膚科診所（如朝陽、馬偕、台大、史考特、新竹國泰皮膚科）
- 丰華皮膚科
- 杏一/大樹/丁丁藥局（處方領藥）
⚠️ 列出僅代表「TW 社群討論度高」，不代表本站推薦或背書。本站不販售任何產品、無導購連結。
- 外用 Minoxidil 2% / 5%
- 口服 Finasteride (停經後可考慮)
查看 ClaimReview 結構化資料 (JSON-LD)
{
"@context": "https://schema.org",
"@type": "ClaimReview",
"url": "https://gpt-dict.com/claim/CLM-COND-fphl-INT-spironolactone-001/",
"datePublished": "2026-06-01",
"author": {
"@type": "Organization",
"name": "gpt-dict.com",
"url": "https://gpt-dict.com"
},
"claimReviewed": "螺內酯 / 安達通能改善女性雄性禿 (FPHL)",
"inLanguage": "zh-TW",
"itemReviewed": {
"@type": "Claim",
"appearance": []
},
"reviewRating": {
"@type": "Rating",
"ratingValue": 4,
"bestRating": 5,
"worstRating": 1,
"alternateName": "🔵 A 中度證據"
}
}